BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Curry EL, Moad M, Robson CN, Heer R. Using induced pluripotent stem cells as a tool for modelling carcinogenesis. World J Stem Cells 2015; 7(2): 461-469 [PMID: 25815129 DOI: 10.4252/wjsc.v7.i2.461]
URL: https://www.wjgnet.com/1948-0210/full/v7/i2/461.htm
Number Citing Articles
1
George M. Ramzy, Thibaud Koessler, Eloise Ducrey, Thomas McKee, Frédéric Ris, Nicolas Buchs, Laura Rubbia-Brandt, Pierre-Yves Dietrich, Patrycja Nowak-Sliwinska. Patient-Derived In Vitro Models for Drug Discovery in Colorectal CarcinomaCancers 2020; 12(6): 1423 doi: 10.3390/cancers12061423
2
Ying Qu, Nur Yucer, Veronica J. Garcia, Armando E. Giuliano, Xiaojiang Cui. Tissue Regeneration2018;  doi: 10.5772/intechopen.76997
3
A Falk, V M Heine, A J Harwood, P F Sullivan, M Peitz, O Brüstle, S Shen, Y-M Sun, J C Glover, D Posthuma, S Djurovic. Modeling psychiatric disorders: from genomic findings to cellular phenotypesMolecular Psychiatry 2016; 21(9): 1167 doi: 10.1038/mp.2016.89
4
Kenly Wuputra, Chang-Shen Lin, Ming-Ho Tsai, Chia-Chen Ku, Wen-Hsin Lin, Ya-Han Yang, Kung-Kai Kuo, Kazunari K. Yokoyama. Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cellsInflammation and Regeneration 2017; 37(1) doi: 10.1186/s41232-017-0041-x
5
Michael Xavier Doss, Agapios Sachinidis. Current Challenges of iPSC-Based Disease Modeling and Therapeutic ImplicationsCells 2019; 8(5): 403 doi: 10.3390/cells8050403
6
Nancy Palechor-Ceron, Ewa Krawczyk, Aleksandra Dakic, Vera Simic, Hang Yuan, Jan Blancato, Weisheng Wang, Fleesie Hubbard, Yun-Ling Zheng, Hancai Dan, Scott Strome, Kevin Cullen, Bruce Davidson, John F. Deeken, Sujata Choudhury, Peter H. Ahn, Seema Agarwal, Xuexun Zhou, Richard Schlegel, Priscilla A. Furth, Chong-Xian Pan, Xuefeng Liu. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living BiobanksCells 2019; 8(11): 1327 doi: 10.3390/cells8111327
7
Ignacio Sancho-Martinez, Emmanuel Nivet, Yun Xia, Tomoaki Hishida, Aitor Aguirre, Alejandro Ocampo, Li Ma, Robert Morey, Marie N. Krause, Andreas Zembrzycki, Olaf Ansorge, Eric Vazquez-Ferrer, Ilir Dubova, Pradeep Reddy, David Lam, Yuriko Hishida, Min-Zu Wu, Concepcion Rodriguez Esteban, Dennis O’Leary, Geoffrey M. Wahl, Inder M. Verma, Louise C. Laurent, Juan Carlos Izpisua Belmonte. Establishment of human iPSC-based models for the study and targeting of glioma initiating cellsNature Communications 2016; 7(1) doi: 10.1038/ncomms10743
8
Herman Yeger. Come together, right now….Journal of Cell Communication and Signaling 2015; 9(3): 283 doi: 10.1007/s12079-015-0301-y
9
Minglin Ou, Min Zhao, Chunhong Li, Donge Tang, Yong Xu, Weier Dai, Weiguo Sui, Yue Zhang, Zhen Xiang, Chune Mo, Hua Lin, Yong Dai. Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytesBiology Open 2021; 10(2) doi: 10.1242/bio.053348
10
Kátia Maria Sampaio Gomes, Ismael Cabral Costa, Jeniffer Farias dos Santos, Paulo Magno Martins Dourado, Maria Fernanda Forni, Julio Cesar Batista Ferreira. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicineRevista da Associação Médica Brasileira 2017; 63(2): 180 doi: 10.1590/1806-9282.63.02.180
11
Yu Seah, Chadi EL Farran, Tushar Warrier, Jian Xu, Yuin-Han Loh. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesInternational Journal of Molecular Sciences 2015; 16(12): 28614 doi: 10.3390/ijms161226119
12
D.A.D. Câmara, A.S. Porcacchia, A.S. Costa, R.A. Azevedo, I. Kerkis. Murine melanoma cells incomplete reprogramming using non‐viral vectorCell Proliferation 2017; 50(4) doi: 10.1111/cpr.12352
13
Shyam A. Patel. Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogrammingCancer Letters 2022; 533: 215579 doi: 10.1016/j.canlet.2022.215579
14
Jie chai, Li Han, Jianbo Zhang, Dali Han, Lei Zou, Ze Zhu, Yulong Zhao, Hongliang Guo. Conditional Reprogramming Inducing Clinical Cells Proliferation: New Research Tools in Tumor and Inflammatory-related DiseasesCurrent Pharmaceutical Design 2020; 26(22): 2657 doi: 10.2174/1381612826666200316155252
15
Larissa Abbehusen Couto de Carvalho, Simone Leal Tosta dos Santos, Lorena Vieira Sacramento, Vildeman Rodrigues de Almeida, Flávia Caló de Aquino Xavier, Jean Nunes dos Santos, Águida Cristina Gomes Henriques Leitão. Mesenchymal stem cell markers in periodontal tissues and periapical lesionsActa Histochemica 2020; 122(8): 151636 doi: 10.1016/j.acthis.2020.151636
16
Zhihan Zhu, Bikram Shah Kalyan, Lukui Chen. Therapeutic potential role of exosomes for ischemic strokeBrain Science Advances 2019; 5(2): 128 doi: 10.1177/2096595820902588
17
Hee Seung Lee, Eunyoung Kim, Jinyoung Lee, Seung Joon Park, Ho Kyoung Hwang, Chan Hee Park, Se-Young Jo, Chang Moo Kang, Seung-Mo Hong, Huapyong Kang, Jung Hyun Jo, In Rae Cho, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Jung Min Han, Sangwoo Kim, Seungmin Bang. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancerEBioMedicine 2021; 65: 103218 doi: 10.1016/j.ebiom.2021.103218
18
Juliana Lopes, David Arnosti, James E. Trosko, Mei-Hui Tai, Debora Zuccari. Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cellsGenes & Cancer 2016; 7(5-6): 209 doi: 10.18632/genesandcancer.107
19
Xuefeng Liu, Ewa Krawczyk, Frank A Suprynowicz, Nancy Palechor-Ceron, Hang Yuan, Aleksandra Dakic, Vera Simic, Yun-Ling Zheng, Praathibha Sripadhan, Chen Chen, Jie Lu, Tung-Wei Hou, Sujata Choudhury, Bhaskar Kallakury, Dean G Tang, Thomas Darling, Rajesh Thangapazham, Olga Timofeeva, Anatoly Dritschilo, Scott H Randell, Christopher Albanese, Seema Agarwal, Richard Schlegel. Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimensNature Protocols 2017; 12(2): 439 doi: 10.1038/nprot.2016.174
20
Martin Müller, Patrick C. Hermann, Stefan Liebau, Clair Weidgang, Thomas Seufferlein, Alexander Kleger, Lukas Perkhofer. The role of pluripotency factors to drive stemness in gastrointestinal cancerStem Cell Research 2016; 16(2): 349 doi: 10.1016/j.scr.2016.02.005
21
Anabela Moreira, Michelle Müller, Pedro F. Costa, Yvonne Kohl. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem CellsAdvanced Biology 2022; 6(2) doi: 10.1002/adbi.202101139
22
Nur Yucer, Rodney Ahdoot, Michael J. Workman, Alexander H. Laperle, Maria S. Recouvreux, Kathleen Kurowski, Diana J. Naboulsi, Victoria Liang, Ying Qu, Jasmine T. Plummer, Simon A. Gayther, Sandra Orsulic, Beth Y. Karlan, Clive N. Svendsen. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesisCell Reports 2021; 37(13): 110146 doi: 10.1016/j.celrep.2021.110146
23
Hana Hříbková, Jana Zelinková, Yuh-Man Sun. Progress in human pluripotent stem cell-based modeling systems for neurological diseasesNeurogenesis 2017; 4(1): e1324258 doi: 10.1080/23262133.2017.1324258
24
Yue Hu, Jochen Gaedcke, Georg Emons, Tim Beissbarth, Marian Grade, Peter Jo, Meredith Yeager, Stephen J. Chanock, Hendrik Wolff, Jordi Camps, B. Michael Ghadimi, Thomas Ried. Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgeryGenes, Chromosomes and Cancer 2018; 57(3): 140 doi: 10.1002/gcc.22512
25
Elisabete Nascimento-Gonçalves, Rita Ferreira, Paula A. Oliveira, Bruno Jorge Antunes Colaço. An Overview of Current Alternative Models for Use in the Context of Prostate Cancer ResearchAlternatives to Laboratory Animals 2020; 48(2): 58 doi: 10.1177/0261192920929701
26
Javad Amini Mahabadi, Hamed Sabzalipour, Hassan Hassani Bafrani, Seyed Mohammad Gheibi Hayat, Hossein Nikzad. Application of induced pluripotent stem cell and embryonic stem cell technology to the study of male infertilityJournal of Cellular Physiology 2018; 233(11): 8441 doi: 10.1002/jcp.26757
27
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, Hamidreza Kabiri, Hosein Salehian-Dehkordi, Mohammad Abdolvand, Sharareh Salmanizadeh, Mohsen Rashidi, Anoosha Niazmand, Saba Ahmadi, Sara Feizbakhshan, Saber Kabiri, Nasimeh Vatandoost, Tayebeh Ranjbarnejad. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapyMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01873-0
28
Alvaro Muñoz-López, Damià Romero-Moya, Cristina Prieto, Verónica Ramos-Mejía, Antonio Agraz-Doblas, Ignacio Varela, Marcus Buschbeck, Anna Palau, Xonia Carvajal-Vergara, Alessandra Giorgetti, Anthony Ford, Majlinda Lako, Isabel Granada, Neus Ruiz-Xivillé, Sandra Rodríguez-Perales, Raul Torres-Ruíz, Ronald W. Stam, Jose Luis Fuster, Mario F. Fraga, Mahito Nakanishi, Gianni Cazzaniga, Michela Bardini, Isabel Cobo, Gustavo F. Bayon, Agustin F. Fernandez, Clara Bueno, Pablo Menendez. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into PluripotencyStem Cell Reports 2016; 7(4): 602 doi: 10.1016/j.stemcr.2016.08.013
29
Teresa de Souza Fernandez, André Luiz Mencalha, Cecília de Souza Fernandez. Recent Advances in Stem CellsStem Cell Biology and Regenerative Medicine 2016; : 131 doi: 10.1007/978-3-319-33270-3_7
30
Abdul M. Mondal, Ai-Hong Ma, Guangzhao Li, Ewa Krawczyk, Ruan Yuan, Jie Lu, Richard Schlegel, Lambros Stamatakis, Keith J. Kowalczyk, George K. Philips, Chong-Xian Pan, Xuefeng Liu. Fidelity of a PDX-CR model for bladder cancerBiochemical and Biophysical Research Communications 2019; 517(1): 49 doi: 10.1016/j.bbrc.2019.06.165
31
Zhihan Zhu, Bikram Shah Kalyan, Lukui Chen. Therapeutic potential role of exosomes for ischemic strokeBrain Science Advances 2019; 5(2): 128 doi: 10.1177/2096595820902588
32
Satish Kumar, John Blangero, Joanne E. Curran. Disease Gene IdentificationMethods in Molecular Biology 2018; 1706: 17 doi: 10.1007/978-1-4939-7471-9_2
33
Sahira Syamimi Ahmad Zawawi, Elyn Amiela Salleh, Marahaini Musa. Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screeningExploration of Targeted Anti-tumor Therapy 2024; 5(2): 409 doi: 10.37349/etat.2024.00226
34
L Charaf, F-X Mahon, I Lamrissi-Garcia, I Moranvillier, F Beliveau, B Cardinaud, S Dabernat, H de Verneuil, F Moreau-Gaudry, A Bedel. Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cellsLeukemia 2017; 31(1): 65 doi: 10.1038/leu.2016.154